| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2009 | US20090221533 Method of treating fatty liver disease |
| 09/03/2009 | US20090221532 Methods Of Dosing Propofol Prodrugs For Inducing Mild To Moderate Levels Of Sedation |
| 09/03/2009 | US20090221531 Novel phytic citrate compounds and process for preparing the same |
| 09/03/2009 | US20090221530 Relaxase Modulators and Methods of Using Same |
| 09/03/2009 | US20090221529 Heterocycles and derivatives thereof and methods of manufacture and therapeutic use |
| 09/03/2009 | US20090221528 Therapeutic micro nutrient composition for lipolysis and sclerosis |
| 09/03/2009 | US20090221527 Tumor necrosis factor inhibitors |
| 09/03/2009 | US20090221526 NGNA Compositions and Methods of Use |
| 09/03/2009 | US20090221525 Functional foods against tumors |
| 09/03/2009 | US20090221524 Odcase inhibitors for the treatment of malaria |
| 09/03/2009 | US20090221523 North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
| 09/03/2009 | US20090221522 Methods to correct gene set expression profiles to drug sensitivity |
| 09/03/2009 | US20090221521 Systemic purine administration: modulating axonal outgrowth of central nervous system neurons |
| 09/03/2009 | US20090221520 Polyene Antibiotics, Compositions Containing Said Antibiotics, Method and Micro-Organisms Used to Obtain Same and Applications Thereof |
| 09/03/2009 | US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 09/03/2009 | US20090221518 Compositions and Methods for Treatment of Exudative Serous Effusion |
| 09/03/2009 | US20090221517 Biologically Active Compounds |
| 09/03/2009 | US20090221516 Novel glycolipid and use thereof |
| 09/03/2009 | US20090221515 Monosaccharide derivatives |
| 09/03/2009 | US20090221511 Trpv1 + sensory neurons control of beta-cell stress and islet inflammation in diabetes |
| 09/03/2009 | US20090221503 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 09/03/2009 | US20090221498 Use of Mas-G-Protein-Coupled Receptor Agonists in the Treatment of the Metabolic Syndrome, Its Components and its Complications |
| 09/03/2009 | US20090221494 Method of modulating cellular activity and agents for use therein |
| 09/03/2009 | US20090221493 Ocl-2a3 compositions and uses thereof |
| 09/03/2009 | US20090221489 Water-Soluable Films Comprising Low-Viscosity Alginates |
| 09/03/2009 | US20090221488 Certain Compositions and Methods of Treatment |
| 09/03/2009 | US20090221486 Method for treating and/or preventing infections in infants delivered via caesarean section |
| 09/03/2009 | US20090221483 Antimicrobial Cathelicidin Peptides |
| 09/03/2009 | US20090221474 Histone deacetylases, and uses related thereto |
| 09/03/2009 | US20090221472 Method for treating transplant rejection |
| 09/03/2009 | US20090221470 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 09/03/2009 | US20090221469 Use of soy kefir powder for reducing pain, blood pressure and inflammation |
| 09/03/2009 | US20090221468 Autonomously Replicating KSHV CIS-Acting Elements |
| 09/03/2009 | US20090221436 Process for determining target function and identifying drug leads |
| 09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
| 09/03/2009 | US20090220625 Synergistic mixtures of bisabolol and ginger extract |
| 09/03/2009 | US20090220622 Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same |
| 09/03/2009 | US20090220621 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 09/03/2009 | US20090220617 Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion |
| 09/03/2009 | US20090220616 Moisturizing and lubricating compositions |
| 09/03/2009 | US20090220612 Hollow-fibre-based biocompatible drug delivery device with one or more layers |
| 09/03/2009 | US20090220610 Suspension Comprising Benzimidazole Carbamate and a Polysorbate |
| 09/03/2009 | US20090220609 Process to control particle size |
| 09/03/2009 | US20090220606 Treatment and prevention of abnormal cellular proliferation |
| 09/03/2009 | US20090220604 Amino acids in micelle preparation |
| 09/03/2009 | US20090220603 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/03/2009 | US20090220602 Sublimable sustained release delivery system and method of making same |
| 09/03/2009 | US20090220599 Antifungal formulation and manufacturing method thereof |
| 09/03/2009 | US20090220598 Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists |
| 09/03/2009 | US20090220597 Rapid release irbesartan-containing pharmaceutical composition |
| 09/03/2009 | US20090220594 Tablet of Paracetamol Containing an Encapsulated Flavorant |
| 09/03/2009 | US20090220593 Extended release dosage forms of quetiapine |
| 09/03/2009 | US20090220591 Pharmaceutical Compositions Comprising Non-Steroidal Antiinflammatory Drug, Antipyretic-Analgesic Drug and Proton Pump Inhibotor |
| 09/03/2009 | US20090220589 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas |
| 09/03/2009 | US20090220587 Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
| 09/03/2009 | US20090220586 Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides |
| 09/03/2009 | US20090220584 Amphoteric Liposome Formulation |
| 09/03/2009 | US20090220583 Method and composition for treating inflammatory disorders |
| 09/03/2009 | US20090220582 Method of cancer treatment using sirna silencing |
| 09/03/2009 | US20090220581 Methods of reducing inflammation and mucus hypersecretion |
| 09/03/2009 | US20090220580 Percutaneous Absorption Formulation |
| 09/03/2009 | US20090220575 Compositions and methods for the sustained release of beta-alanine |
| 09/03/2009 | US20090220574 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 09/03/2009 | US20090220572 Injectable Combination Therapy for Eye Disorders |
| 09/03/2009 | US20090220571 Self-expanding devices and methods therefor |
| 09/03/2009 | US20090220570 Axon Regeneration with PKC Inhibitors |
| 09/03/2009 | US20090220562 Osteogenic and anti-adipogenic oxysterols |
| 09/03/2009 | US20090220554 Transglutaminase Inhibitors and Methods of Use Thereof |
| 09/03/2009 | US20090220552 Formulations containing pantoprazole free acid and its salts |
| 09/03/2009 | US20090220538 vaccine for staphylococcal infections |
| 09/03/2009 | US20090220532 Agents and methods based on the use of the eda domian of fibronectin |
| 09/03/2009 | US20090220531 Composition of which Chief Ingredient is Polysaccharides Having an Immunoregulatory Function |
| 09/03/2009 | US20090220528 Stimulation of Toll-Like Receptors on T Cells |
| 09/03/2009 | US20090220516 Neuroprotection of retinal ganglion cells |
| 09/03/2009 | US20090220514 ADAM10 and its Uses Related to Infection |
| 09/03/2009 | US20090220513 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 09/03/2009 | US20090220512 Genes and polypeptides relating to prostate cancers |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220503 Method for treating cancers with increased ras signaling |
| 09/03/2009 | US20090220498 Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma |
| 09/03/2009 | US20090220495 Cancer Related Genes (PRLR) |
| 09/03/2009 | US20090220488 Evaluating and treating scleroderma |
| 09/03/2009 | US20090220487 via blocking proteins and signal transduction pathways, with peptide which inhibits p21-activated kinase (PAK)-PIX-GIT interaction or complex formation; mitogen-activated protein kinase inhibitors; tissue damage, ischemia, inflammation, stroke, wound healing, acute respiratory distress syndrome |
| 09/03/2009 | US20090220477 Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult |
| 09/03/2009 | US20090220476 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof |
| 09/03/2009 | US20090220473 Adir related polymorphisms and applications thereof |
| 09/03/2009 | US20090220470 Ubiquitin binding polypeptides |
| 09/03/2009 | US20090220469 Peptides against autoantibodies associated with glaucoma and use of these peptides |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | US20090220458 Pseudotyped retroviral vectors and methods of use thereof |
| 09/03/2009 | US20090220457 Combinations comprising hcv protease inhibitor(s) and hcv ires inhibitor(s), and methods of treatment related thereto |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090220453 Enhancing stem cell mobilization |
| 09/03/2009 | US20090220451 Cyclopropyl compounds and compositions for delivering active agents |
| 09/03/2009 | US20090220450 Methods and compositions for wound healing |
| 09/03/2009 | US20090220449 Substituted organopolysiloxanes and uses thereof |
| 09/03/2009 | US20090220435 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 09/03/2009 | US20090220433 Novel biotinylated compositions |
| 09/03/2009 | US20090220422 Drug Delivery Material |
| 09/03/2009 | US20090220420 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr) |